Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What CAGR And Valuation Are Anticipated For The Generalized Anxiety Disorder Market?
Recent years have seen a consistent growth in the market size of generalized anxiety disorder. Projected to increase from $7.76 billion in 2024 to $7.93 billion in 2025, the market will witness a compound annual growth rate (CAGR) of 2.2%. This growth during the historic period stems from heightened mental health awareness, advancements in the pharmaceutical industry, the implementation of cognitive-behavioral therapy (CBT), and changes in lifestyle causing increased stress.
Anticipated to witness a consistent rise in the near future, the market size for generalized anxiety disorder is projected to soar to $9.2 billion in 2029, with a compound annual growth rate (CAGR) of 3.8%. The growth during the forecast period can be linked to advancements in digital mental health solutions, genetic research, consolidated care models, and increased awareness of mental health worldwide. The future trends lying ahead mainly encompass holistic methodologies, cultural proficiency, early prevention methods, and the use of artificial intelligence (AI) in diagnosis.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13039&type=smp
What Core Drivers Are Expected To Influence The Generalized Anxiety Disorder Market?
Increasing mental disorder incidences in the healthcare sector are fueling the expansion of the generalized anxiety disorder market. The term mental disorder, synonymous with mental illness, encompasses a broad set of conditions influencing an individual’s thoughts, feelings, behaviors, and overall mental health. Mental health disorders frequently co-occurring with generalized anxiety disorder are phobias, panic disorder, post-traumatic stress disorder (PTSD), and obsessive-compulsive disorder (OCD). It is essential to manage these disorders properly for maintaining a healthy relationship and enhancing life quality. For example, in the Stress in America 2023 survey conducted by the US-based American Psychological Association in November 2023, there was a notable surge in mental health diagnoses among adults aged 35 to 44, where 45% reported having a mental illness in 2023 compared to 31%. Still, the highest mental illness rate was reported in the 18 to 34 age group at 50% in 2023. Thus, the growth of the generalized anxiety disorder market is likely to be motivated by the increasing cases of mental disorders.
What Are The Main Segment Classifications In The Generalized Anxiety Disorder Market?
The generalized anxiety disordermarket covered in this report is segmented –
1) By Type: Panic Disorder; Agoraphobia; Generalized Anxiety; Social Anxiety; Specific Phobia; Other Types
2) By Therapies: Interpersonal Therapy; Behavior Therapy; Cognitive Behavioral Therapy; Mindfulness Based Cognitive Therapy
3) By Device: Deep Brain Stimulation; Electroconvulsive Therapy; Transcranial Magnetic Stimulation; Vagus Nerve Stimulation
4) By End-User: Hospitals; Homecare; Specialty Clinics; Other End-Users
Subsegments:
1) By Panic Disorder: Recurrent Panic Attacks; Unexpected Panic Attacks
2) By Agoraphobia: Situational Phobia; Open Spaces Anxiety
3) By Generalized Anxiety: Chronic Worry; Excessive Anxiety
4) By Social Anxiety: Performance Anxiety; Interaction Anxiety
5) By Specific Phobia: Animal Phobia; Environmental Phobia; Situational Phobia
6) Other Type: Separation Anxiety Disorder; Selective Mutism; Post-Traumatic Stress Disorder (PTSD)
Which Emerging Trends Are Reshaping The Generalized Anxiety Disorder Market Landscape?
Leading firms in the generalized anxiety disorder market are making headway in the creation of ground-breaking drugs like MM-120 and attaining endorsement for their treatments to cater better to their patient’s needs. Drugs like MM-120 are designed to enhance the treatment and results of this mental health issue. For example, Mind Medicine Inc., a US psychedelic medicine biotech corporation, received a green light for their Investigational New Drug (IND) application from the U.S. Food and Drug Administration (FDA) in January 2022. This approval will allow the commencement of a phase IIb trial of MM-120 for the management of generalized anxiety disorder (GAD). MM-120, a minor molecule, functions as a partial agonist of the 5-HT2A receptor, which is crucial in mood, anxiety, and perception regulation. Moreover, it is believed that MM-120 boosts serotonin levels in the brain, paving a way for the development of other psychedelic compounds to combat mental health disorders.
Which Companies Are Contributing Significantly To The Generalized Anxiety Disorder Market Growth?
Major companies operating in the generalized anxiety disorder market are Alkermes PLC, Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi SA, Bristol-Myers Squibb, GlaxoSmithKline PLC, AstraZeneca PLC, Abbott Laboratories, 3M Company, Boehringer Ingelheim International GmbH, Johnson And Johnson Private Limited, Adobe Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Otsuka Holdings Co. Ltd., Mylan N.V., Sumitomo Pharma Co. Ltd., Jazz Pharmaceuticals PLC, Forest Laboratories Inc., H. Lundbeck A/S, Shionogi and Company, Neurocrine Biosciences Inc., Actavis Pharmaceutical Company, Eli Lilly and Company, Noven Pharmaceuticals Inc., Mind Medicine Inc., Sage Therapeutics Inc., Bionomics Ltd., Recordati Rare Diseases SARL, VistaGen Therapeutics Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/generalized-anxiety-disorder-global-market-report
Which Region Holds The Greatest Opportunity For Generalized Anxiety Disorder Market Expansion?
North America was the largest region in the generalized anxiety disorder market in 2024. The regions covered in generalized anxiety disorder market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=13039&type=smp
Browse Through More Reports Similar to the Global Generalized Anxiety Disorder Market 2025, By The Business Research Company
Mental Health Apps Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/mental-health-apps-global-market-report
Behavioral And Mental Health Software Global Market Report 2025
Residential Substance Abuse And Mental Health Facilities Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model